accaccordingacuteadministrationadverseahaamericanamonganalysisantagonistsantiplateletaorticapixabanarterialarteryaspirinassociatedassociationatheroscleroticatrialbasedbenefitsbetableedingblockerblockersbloodbypasscardiaccardiogeniccardiomyopathycardiovascularcarotidcenterchronicclinicalclopidogrelcohortcombinationcombinedcomparedcomparisoncongresscontemporarycontrolledcoronarycriticallydaptdatadiabetesdirecteddiseasedrugdualearlyeffecteffectivenesseffectsefficacyejectionelevationendovascularesceventsfactorsfailurefibrillationflowfollowingfractionfunctiongraftingguidelineguidelineshbrhearthfhfpefhfrefhighhighlightshospitalhypertensionhypertrophicillimpactimprovesincidenceindividualinfarctinfarctioninhibitorinhibitorsinitiationinjuryinsightsinterventionischemickeyleftlevellonglowermajormanagementmedicalmellitusmetametoprololmildlymitralmoderatemonotherapymonthmortalitymyocardialnationwideobstructiveocclusiononsetoraloutcomesp2y12patientpatientspatternspcipediatricpercutaneousperipheralpharmacologicalplateletpluspointspostpreservedpressurepretreatmentpreventionprimaryproceduresprognosticpulmonaryrandomizedrapidraterealreceptorreducedreductionregimenregistryregurgitationremodelingrepairreperfusionresultsretrospectiverevascularizationreviewriskrivaroxabansafetysecondarysegmentseveresexsglt2shockshortsizestemistentingstrokestudysyndromesyndromessystematicsystemictermtherapyticagrelortotaltranscathetertreatedtreatmenttreatmentstrialtrialstwilighttypeundergoingusevaluevalveventricularversuswithoutworldyoung